Patents by Inventor Luke JASENOSKY

Luke JASENOSKY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of infectious diseases
    Patent number: 10765664
    Abstract: Disclosed herein are methods for treating or preventing a disease comprising administering a pharmaceutical composition comprising a therapeutically-effective amount of nitazoxanide to a subject having the disease, wherein the disease is causally linked to infection by one or more pathogens selected from the group consisting of members of the genus Ebolavirus, members of the genus Marburgvirus, members of the species dengue virus, human immunodeficiency viruses 1 and 2, and members of the species Mycobacterium tuberculosis.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: September 8, 2020
    Assignee: Children's Medical Center Corporation
    Inventors: Anne Goldfeld, Luke Jasenosky, Viraga Haridas, Shahin Ranjbar
  • TREATMENT OF INFECTIOUS DISEASES
    Publication number: 20190247367
    Abstract: Disclosed herein are methods for treating or preventing a disease comprising administering a pharmaceutical composition comprising a therapeutically-effective amount of nitazoxanide to a subject having the disease, wherein the disease is causally linked to infection by one or more pathogens selected from the group consisting of members of the genus Ebolavirus, members of the genus Marburgvirus, members of the species dengue virus, human immunodeficiency viruses 1 and 2, and members of the species Mycobacterium tuberculosis.
    Type: Application
    Filed: April 23, 2019
    Publication date: August 15, 2019
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Anne GOLDFELD, Luke JASENOSKY, Viraga HARIDAS, Shahin RANJBAR
  • TREATMENT OF INFECTIOUS DISEASES
    Publication number: 20180098972
    Abstract: Disclosed herein are methods for treating or preventing a disease comprising administering a pharmaceutical composition comprising a therapeutically-effective amount of nitazoxanide to a subject having the disease, wherein the disease is causally linked to infection by one or more pathogens selected from the group consisting of members of the genus Ebolavirus, members of the genus Marburgvirus, members of the species dengue virus, human immunodeficiency viruses 1 and 2, and members of the species Mycobacterium tuberculosis.
    Type: Application
    Filed: January 26, 2016
    Publication date: April 12, 2018
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Anne GOLDFELD, Luke JASENOSKY, Viraga HARIDAS, Shahin RANJBAR